AGASAC frequently expressed PDGFRβ in a high percentage of neoplastic cells and in tumor stromal compartments with high intensity, supporting the addition of TKIs to AGASAC treatment, especially in tubular tumors. Here, PDGFRB is linked to neoplasm.